Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorFujian Cancer Hospital
About this trial
The main objective of this study was to evaluate the efficacy and safety of drug retention enema for the prevention of acute radiation rectal injury in the real world.
Eligibility criteria
Qualifiers
There are clear indications for radiotherapy (pelvic radiotherapy or rectal radiotherapy) according to relevant guidelines;
ECOG score 0-1;
normal mind, clear consciousness;
High compliance;
Disqualifiers
Poor compliance, unwilling to participate or unable to cooperate with the interviewer;
Patients with other intestinal diseases (such as Crohn's disease, rectal ulcer, anal fissure, anal fistula, hemorrhoids, etc.) and perianal diseases;
serious heart, brain, liver, kidney disease;
Long-term immune dysfunction;
Trial design
Treatments tested in this trial
- Triethanolamine cream
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
1The First Affiliated Hospital of Xiamen University361003, XiamenFujian, China
Sponsors and collaborators
Fujian Cancer Hospital
Lead sponsor
Source ClinicalTrials.gov